$27.81−1.07 (−3.71%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Immunocore Holdings (IMCR) Institutional Ownership
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
Sources Ownership filingsQuarter ended How we compute thisNot investment advice
1 figure withheld by our checks. Each blank figure names its reason.
13F fund flowQuarter ended Sep 30, 2026*: more funds added or entered than trimmed or exited, mild accumulation (6 new · 26 increased · 14 reduced · 8 closed · 1 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 55 filers, Sep 30, 2026
# 13F FUNDS
55
13F VALUE
$312.3M
10.3M shares
Withheld: 13F filers report depositary receipts and the company reports ordinary shares, so the two do not divide.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| May 27, 2026 | Bell John Irving | director | Acquired · Grant / award | 27,492Share Option (Right to Buy) | — | ↗ |
| May 27, 2026 | Kaul Siddharth | director | Acquired · Grant / award | 27,492Share Option (Right to Buy) | — | ↗ |
| May 27, 2026 | Herbst Roy Steven | director | Acquired · Grant / award | 27,492Share Option (Right to Buy) | — | ↗ |
| May 27, 2026 | Ratcliffe Peter John | director | Acquired · Grant / award | 27,492Share Option (Right to Buy) | — | ↗ |
| May 27, 2026 | Pao William | director | Acquired · Grant / award | 27,492Share Option (Right to Buy) | — | ↗ |
| May 27, 2026 | Peterson Kristine | director | Acquired · Grant / award | 27,492Share Option (Right to Buy) | — | ↗ |
| Feb 18, 2026 | St Leger Tina Amber | CHIEF HR OFFICER | Disposed · Open-market sale | 1,000 | $32.35 | ↗ |
| Feb 18, 2026 | Berman David M | HEAD OF R&D | Disposed · Open-market sale | 5,965 | $32.35 | ↗ |
| Feb 18, 2026 | GOLL JOHN | SVP, FINANCE & CAO | Disposed · Open-market sale | 698 | $32.35 | ↗ |
| Feb 18, 2026 | Jallal Bahija | CHIEF EXECUTIVE OFFICER | Disposed · Open-market sale | 11,474 | $32.35 | ↗ |
| Feb 17, 2026 | St Leger Tina Amber | CHIEF HR OFFICER | Acquired · Option exercise | 2,119 | — | ↗ |
| Feb 17, 2026 | St Leger Tina Amber | CHIEF HR OFFICER | Disposed · Option exercise | 2,119Restricted Share Units | — | ↗ |
| Feb 17, 2026 | Coy Travis Alan | Chief Financial Officer | Acquired · Grant / award | 33,353Restricted Share Units | — | ↗ |
| Feb 17, 2026 | Coy Travis Alan | Chief Financial Officer | Acquired · Grant / award | 95,637Employee Share Option (Right to Buy) | — | ↗ |
| Feb 17, 2026 | Berman David M | HEAD OF R&D | Acquired · Option exercise | 11,824 | — | ↗ |
| Feb 17, 2026 | Berman David M | HEAD OF R&D | Disposed · Option exercise | 11,824Restricted Share Units | — | ↗ |
| Feb 17, 2026 | GOLL JOHN | SVP, FINANCE & CAO | Acquired · Option exercise | 1,351 | — | ↗ |
| Feb 17, 2026 | GOLL JOHN | SVP, FINANCE & CAO | Disposed · Option exercise | 1,351Restricted Share Units | — | ↗ |
| Feb 17, 2026 | GOLL JOHN | SVP, FINANCE & CAO | Acquired · Grant / award | 7,411Restricted Share Units | — | ↗ |
| Feb 17, 2026 | GOLL JOHN | SVP, FINANCE & CAO | Acquired · Grant / award | 21,252Employee Share Option (Right to Buy) | — | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How many 13F filers hold Immunocore Holdings?
Immunocore Holdings was held by 55 13F filers as of Sep 30, 2026.
Not investment advice.

